Polihexanide (PHMB) Eye Drops in Patients Affected by Acanthamoeba Keratitis

计划入组 135 人 · 首次发布于 2017 年 9 月 7 日

Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide

计划入组 40 人 · 首次发布于 2024 年 10 月 15 日

Parasitic Ulcer Treatment Trial

计划入组 232 人 · 首次发布于 2024 年 1 月 19 日

Fungal keratitis(Cipla)

allogeneic human blood serum therapy (Neurotrophic Keratitis)

mesenchymal stem cell-derived exosomes (neurotrophic keratitis)

Oculis

Switzerland

Hepatitis Resource Network

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

AKANTIOR® Receives UK Marketing Authorization as First Approved Treatment for Acanthamoeba Keratitis

SIFI Advances Regulatory Pathway for AKANTIOR® in the UK and US for Acanthamoeba Keratitis

SIFI Receives European Patent for Polihexanide and Launches AKANTIOR® in Germany